TERRA protection of telomeres from the persistent activation of DNA-damage response was initially suggested by the appearance of telomeric dysfunction in ALT cancer cells and in human diploid fibroblasts respectively deprived of TERRA and its transcriptional regulator mixed-lineage leukemia (MLL) [22,31,32]. Here, KMT2A is linked to cancer.